PERSPECTIVE THERAPEUTICS, INC. (CATX)

3.16USD +1.61% (+0.05)

Over 1M: +5.0%

Style
Area Line Line with markers Steps Candles Hollow candles Bars

Candles and bars need the day’s open, high and low, and need room to be drawn in: past about a year of trading a body is thinner than a hairline, so those three offer the longest window that fits instead.

3 3.2 3.4
3 Aug 6 Aug 11 Aug 14 Aug 19 Aug 24 Aug 27 Aug

Financials Quarterly

Figures
Revenue Gross Profit Operating Income Cost of Revenue Operating Cash Flow Free Cash Flow Net Income

A share count and earnings a share are not here: neither is money, so neither can share this axis. Both have their own panel on All charts.

All charts ›
Q3 '21 — Net Income: -2.2M Q4 '21 — Net Income: -1.6M Q1 '22 — Net Income: -1.3M Q2 '22 — Net Income: -2.1M Q3 '22 — Net Income: -4.1M Q4 '22 — Net Income: -3.3M Q1 '23 — Net Income: -371K Q2 '23 — Net Income: -11.1M Q3 '23 — Net Income: -10.4M Q4 '23 — Net Income: -24.7M Q1 '24 — Net Income: -12.3M Q2 '24 — Net Income: -11.7M Q3 '24 — Net Income: -15.1M Q4 '24 — Net Income: -40.2M Q1 '25 — Net Income: -18.2M Q2 '25 — Net Income: -21.5M Q3 '25 — Net Income: -26M Q4 '25 — Net Income: -37.5M Q1 '26 — Net Income: -26.2M Q2 '26 — Net Income: -26.8M -36M -27M -18M -9M 0
Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26
Net Income

Figures as at 2026-06-30, reported in USD. The newest fact in the filings is dated 2026-06-30, 62 days ago. Nothing on this page is advice.

How it scores

Five questions, each answered by the measures under it. Every figure is the company's own; the bar beside it is where that figure sits among the companies read here — the top fifth, the bottom fifth, or somewhere between. Not among all listed companies, and for a valuation multiple the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

0.5
ROIC -111.7%
Accruals -6.0%
Asset turnover 0.001×
ROA -29.7%
ROCE -35.2%
ROE -36.0%
Capex / sales —
EBITDA margin —
FCF margin —
Gross margin —
OCF / EBIT —
OCF margin —
OE margin —
Oper. margin —
Profit margin —
SBC / sales —

1 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

0.8
EV/Sales 299.7×
EV/OE -0.93×
P/C 1.5×
P/B 1.1×
FCF yield -33.9%
Div. yield —
EV/EBIT —
EV/GP —
Fwd P/E —
P/E —
PEG —

2 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

1.0
RPO / sales —
RPO growth —
Segment HHI —

2 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

7.4
ND/EBITDA 1.9
Cash runway 1.9 yr
Cash / Debt 148.3×
Debt / Eq 0.0049×
Debt payback 0.0 yr
Quick ratio 6.6×
F-score 1.1 pts
Interest cover —
Payout —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

1.0
Sales/sh Y/Y -71.1%
Sales Q/Q -72.1%
Shares change +14.6%
Div. growth —
EBIT CAGR —
EBIT Y/Y —
EPS CAGR 4Y —
EPS Y/Y —
EPS next Y —
Sales CAGR 4Y —

2 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.